Elixirr International (ELIX) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
24 Apr, 2026Executive summary
Achieved record financial results with revenue of GBP 149.6 million, up 34% year-over-year, and adjusted EBITDA of GBP 44.3 million, up 42% year-over-year, driven by strong advisory demand and AI-led growth.
AI is now the fastest-growing segment, with AI-related revenue up 260% and project count up over 135% year-over-year, becoming core to delivery and client value.
Strategic acquisitions, notably TRC Advisory and Kvadrant, have diversified capabilities, geographies, and industries, supporting robust cross-sell and integration.
Employee ownership remains a core cultural driver, with 84% participation in the ESPP and over 35,000 applications in FY 25.
Client base continues to deepen, with gold clients (GBP 1m+ revenue) rising from 27 to 34 and top 10 clients spanning 7 industries and all key geographies.
Financial highlights
Revenue reached GBP 149.6 million, up 34% year-over-year; organic revenue growth was 15.3%.
Adjusted EBITDA margin improved to 29.6%, up 1.6 percentage points.
Adjusted diluted EPS increased 36% year-over-year to 58.7p.
Free cash flow was GBP 31.1 million, up 11% year-over-year.
Final dividend for FY 2025 totals GBP 0.226, up 27% year-over-year, with dividend cover at 2.8x.
Outlook and guidance
Entered FY 26 with strong momentum, record Q1 revenue, and 18 gold clients already secured.
Continued focus on organic and inorganic growth, targeting FTSE 250 entry within 12–18 months.
Expectation of 10–20% organic growth, with similar contribution from acquisitions.
Client demand increasingly focused on AI-enabled, digital, and data-driven transformation.
Ongoing investment in capabilities, acquisitions, and geographic expansion to support long-term growth.
Latest events from Elixirr International
- Revenue, EBITDA, and dividend growth drive record performance and FTSE 250 ambitions.ELIX
H2 2025 TU22 Jan 2026 - Record H1 2024 revenue and EBITDA growth, strong cash flow, and positive FY24 outlook.ELIX
H1 202419 Jan 2026 - Record FY24 growth, US expansion, and Main Market move set stage for continued outperformance.ELIX
H2 20247 Jan 2026 - 35% revenue and 42% EBITDA growth, Main Market move, and TRC deal drive strong outlook.ELIX
H1 202521 Dec 2025 - FY24 results beat expectations, with strong growth, high margins, and full debt repayment.ELIX
H2 2024 TU8 Oct 2025 - Record revenue growth and strong margins in H1 2025, with a confident outlook for FY 2025.ELIX
H1 2025 TU8 Oct 2025